Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Guida A, Gili A, Mosillo C, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Fornarini G, Rebuzzi SE, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S.
Guida A, et al. Among authors: serafin d.
Clin Genitourin Cancer. 2024 Dec;22(6):102225. doi: 10.1016/j.clgc.2024.102225. Epub 2024 Sep 14.
Clin Genitourin Cancer. 2024.
PMID: 39405768